HIS
IRWD icon

Harvest Investment Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Harvest Investment Services’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$849K Buy
241,881
+221,711
+1,099% +$909K 0.16% 139
2025
Q4 		$68K Buy
+20,170
New +$52.4K 0.01% 325

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Harvest Investment Services's IRWD Position: Q1 2026 in Review

Harvest Investment Services increased its Ironwood Pharmaceuticals (IRWD) stake by 1,099% in Q1 2026, buying an estimated $909K and bringing the position to 241,881 shares worth $849K. The position accounts for 0.16% of the portfolio, ranked #139.

Harvest Investment Services first reported a position in IRWD in Q4 2025 and has held it in 2 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Harvest Investment Services held 241,881 shares of Ironwood Pharmaceuticals worth $849K as of Q1 2026.
  • Harvest Investment Services bought 221,711 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $909K.
  • Ironwood Pharmaceuticals made up 0.16% of Harvest Investment Services's portfolio in Q1 2026, its #139 holding.
  • Harvest Investment Services first reported a position in Ironwood Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Harvest Investment Services's 13F filing for Q1 2026, filed 15 May 2026.